Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00341705 · ClinicalTrials.gov registry record
The Second Multicenter Hemophilia Cohort Study
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 2,565
- Enrollment target
NCT00341705: Completed study, sponsored by National Cancer Institute (NCI).
NCT00341705 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,565 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00341705 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 2,565 participants
- Enrollment target
Study Summary
The Second Multicenter Hemophilia Cohort Study (MHCS-II) will evaluate and prospectively follow approximately 4500 persons with hemophilia who were exposed to hepatitis C virus (HCV). The vast majority will have been infected with HCV, and approximately 1/3 will have been infected with human immunodeficiency virus (HIV). Primary objectives are to quantify the rates of liver decompensation, hepatocellular carcinoma, and non-Hodgkin lymphoma and to evaluate candidate clinical, genetic, virologic, serologic and immunologic markers that are likely to be on the causal pathway for these conditions. Candidate clinical and laboratory markers will be examined longitudinally to define changes over time and their relationships to one another. Collaborative studies will focus on genome scanning and evaluation of candidate genetic loci for susceptibility or resistance to HCV and HIV infections or to the diseases that result from these infections. Additional studies will identify response and complication rates of various anti-HCV and anti-HIV regimens in the setting of comprehensive clinical care of persons with hemophilia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,565 participants |
| Start Date | 2001-04-27 |
| Est. Completion | 2013-04-02 |
What the finished NCT00341705 record still lists
NCT00341705 is an observational study that tracks outcomes without assigning an intervention. Its 2,565 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00341705 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00341705 about?
NCT00341705 is a clinical study titled "The Second Multicenter Hemophilia Cohort Study". The Second Multicenter Hemophilia Cohort Study (MHCS-II) will evaluate and prospectively follow approximately 4500 persons with hemophilia who were exposed to hepatitis C virus (HCV). The vast majority will have been infected with HCV, and approximately 1/3 will have been infected with human immunod...
What is the current status of trial NCT00341705?
This trial is currently completed. The enrollment target is 2,565 participants. The study started on 2001-04-27. Estimated completion is 2013-04-02.
Who is sponsoring clinical trial NCT00341705?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06018285 · 2,572 participants · NA
Stepped Approach to Reducing Risk of Suicide in Primary Care
- NCT05931276 · 2,540 participants · Phase 3
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- NCT06370520 · 2,592 participants
Screening Emotions in Adolescents at the Hospital for mTBI
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI